A detailed history of Jim Simons (Renaissance Technologies LLC) transactions in Dario Health Corp. stock. As of the latest transaction made, Renaissance Technologies LLC holds 87,700 shares of DRIO stock, worth $61,389. This represents 0.0% of its overall portfolio holdings.

Number of Shares
87,700
Previous 91,700 4.36%
Holding current value
$61,389
Previous $109,000 10.09%
% of portfolio
0.0%
Previous 0.0%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$0.78 - $1.45 $3,120 - $5,800
-4,000 Reduced 4.36%
87,700 $98,000
Q2 2024

Aug 09, 2024

SELL
$1.09 - $1.9 $3,815 - $6,650
-3,500 Reduced 3.68%
91,700 $109,000
Q1 2024

May 13, 2024

BUY
$1.4 - $2.55 $10,080 - $18,360
7,200 Added 8.18%
95,200 $146,000
Q4 2023

Feb 13, 2024

BUY
$1.0 - $3.39 $10,900 - $36,951
10,900 Added 14.14%
88,000 $151,000
Q3 2023

Nov 14, 2023

BUY
$2.6 - $4.23 $31,460 - $51,183
12,100 Added 18.62%
77,100 $253,000
Q2 2023

Aug 11, 2023

BUY
$3.2 - $4.33 $22,931 - $31,028
7,166 Added 12.39%
65,000 $261,000
Q1 2023

May 12, 2023

BUY
$3.79 - $6.22 $151,728 - $249,011
40,034 Added 224.91%
57,834 $238,000
Q4 2022

Feb 13, 2023

BUY
$3.53 - $5.49 $62,834 - $97,722
17,800 New
17,800 $76,000
Q2 2022

Aug 12, 2022

BUY
$4.33 - $7.45 $151,983 - $261,495
35,100 Added 57.45%
96,200 $591,000
Q1 2022

May 13, 2022

BUY
$5.84 - $13.61 $356,824 - $831,571
61,100 New
61,100 $357,000
Q1 2021

May 13, 2021

SELL
$15.41 - $30.42 $590,203 - $1.17 Million
-38,300 Closed
0 $0
Q4 2020

Feb 10, 2021

BUY
$10.17 - $17.12 $389,511 - $655,696
38,300 New
38,300 $547,000
Q3 2020

Nov 13, 2020

SELL
$6.12 - $20.65 $104,652 - $353,115
-17,100 Closed
0 $0
Q2 2020

Aug 13, 2020

BUY
$5.12 - $9.45 $87,552 - $161,595
17,100 New
17,100 $109,000

Others Institutions Holding DRIO

About DarioHealth Corp.


  • Ticker DRIO
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 23,295,000
  • Market Cap $16.3M
  • Description
  • DarioHealth Corp. operates as a digital therapeutics company in the United States, Canada, the European Union, Australia, and New Zealand. The company offers Dario's metabolic solutions to address metabolic health needs, such as diabetes, hypertension, and weight management; Dario Musculoskeletal, which helps to prevent and treat the most common...
More about DRIO
Track Jim Simons's Portfolio

Track Jim Simons Portfolio

Follow Jim Simons (Renaissance Technologies LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Renaissance Technologies LLC, based on Form 13F filings with the SEC.

News

Stay updated on Renaissance Technologies LLC and Jim Simons with notifications on news.